Morning Industry Symposium: New data in breast cancer genomic testing to advance personalized treatment decisions
Supported by Veracyte

Friday, October 09, 2026 | Hall B (Great Hall 2)
07:30-08:30
Light refreshments will be served outside the hall from 07:00-07:30 for session participants only.
Admission to this symposium is included as part of the congress registration

Chairperson: Kelly Marcom, Durham ,NC, USA
07:30-07:45 OPTIMA: Results
Stuart McIntosh, Belfast, Ireland
07:45-08:00 The Australian perspective, and the importance of OPTIMA Young
Belinda Kiely, Sydney, Australia
08:00-08:15 Case studies and practical implementation
Nick Zdenkowski, Newcastle, Australia
08:15-08:30 Q & A

 

Skip to content